Alendronate Sodium (Page 8 of 8)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 10 mg (30 Tablets Bottle)

NDC 65862-327-30
Rx only
Alendronate Sodium
Tablets, USP
10 mg*
PHARMACIST: Dispense the accompanying
Medication Guide to each patient. AUROBINDO 30 Tablets

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 10 mg (30 Tablets Bottle)
(click image for full-size original)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 10 mg Blister Carton 100 (10 x 10) Unit-dose Tablets

NDC 65862-327-10 Rx only
Alendronate Sodium Tablets, USP
10 mg*
PHARMACIST: Dispense the accompanying Medication Guide to each patient. AUROBINDO 100 (10 x 10) Unit-dose Tablets

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 10 mg Blister Carton 100 (10 x 10) Unit-dose Tablets
(click image for full-size original)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 35 mg Blister Carton (4 Unit-of-use)

NDC 65862-328-04
ONCE WEEKLY
Alendronate Sodium Tablets, USP
35 mg*
PHARMACIST: Dispense the accompanying
Medication Guide to each patient.
Rx only 4 Tablets AUROBINDO

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 35 mg Blister Carton (4 Unit-of-use)
(click image for full-size original)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 70 mg Blister Carton (4 Unit-of-use)

NDC 65862-329-04
ONCE WEEKLY
Alendronate Sodium Tablets, USP
70 mg*
PHARMACIST: Dispense the accompanying
Medication Guide to each patient.
Rx only 4 Tablets AUROBINDO

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 70 mg Blister Carton (4 Unit-of-use)
(click image for full-size original)
ALENDRONATE SODIUM alendronate sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65862-327
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ALENDRONATE SODIUM (ALENDRONIC ACID) ALENDRONIC ACID 10 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
POVIDONE K30
SODIUM STARCH GLYCOLATE TYPE A POTATO
Product Characteristics
Color WHITE (White to Off-white) Score no score
Shape ROUND (Biconvex) Size 5mm
Flavor Imprint Code F;18
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:65862-327-30 30 TABLET in 1 BOTTLE None
2 NDC:65862-327-01 100 TABLET in 1 BOTTLE None
3 NDC:65862-327-99 1000 TABLET in 1 BOTTLE None
4 NDC:65862-327-10 10 BLISTER PACK in 1 CARTON contains a BLISTER PACK
4 10 TABLET in 1 BLISTER PACK This package is contained within the CARTON (65862-327-10)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090124 08/04/2008
ALENDRONATE SODIUM alendronate sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65862-328
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ALENDRONATE SODIUM (ALENDRONIC ACID) ALENDRONIC ACID 35 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
POVIDONE K30
SODIUM STARCH GLYCOLATE TYPE A POTATO
Product Characteristics
Color WHITE (White to Off-white) Score no score
Shape OVAL (Biconvex) Size 10mm
Flavor Imprint Code F;19
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:65862-328-04 1 BLISTER PACK in 1 CARTON contains a BLISTER PACK
1 4 TABLET in 1 BLISTER PACK This package is contained within the CARTON (65862-328-04)
2 NDC:65862-328-08 3 BLISTER PACK in 1 CARTON contains a BLISTER PACK
2 4 TABLET in 1 BLISTER PACK This package is contained within the CARTON (65862-328-08)
3 NDC:65862-328-20 5 BLISTER PACK in 1 CARTON contains a BLISTER PACK
3 4 TABLET in 1 BLISTER PACK This package is contained within the CARTON (65862-328-20)
4 NDC:65862-328-10 10 BLISTER PACK in 1 CARTON contains a BLISTER PACK
4 10 TABLET in 1 BLISTER PACK This package is contained within the CARTON (65862-328-10)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090124 08/04/2008
ALENDRONATE SODIUM alendronate sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:65862-329
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ALENDRONATE SODIUM (ALENDRONIC ACID) ALENDRONIC ACID 70 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
POVIDONE K30
SODIUM STARCH GLYCOLATE TYPE A POTATO
Product Characteristics
Color WHITE (White to Off-white) Score no score
Shape OVAL (Biconvex) Size 13mm
Flavor Imprint Code F;21
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:65862-329-04 1 BLISTER PACK in 1 CARTON contains a BLISTER PACK
1 4 TABLET in 1 BLISTER PACK This package is contained within the CARTON (65862-329-04)
2 NDC:65862-329-08 3 BLISTER PACK in 1 CARTON contains a BLISTER PACK
2 4 TABLET in 1 BLISTER PACK This package is contained within the CARTON (65862-329-08)
3 NDC:65862-329-20 5 BLISTER PACK in 1 CARTON contains a BLISTER PACK
3 4 TABLET in 1 BLISTER PACK This package is contained within the CARTON (65862-329-20)
4 NDC:65862-329-10 10 BLISTER PACK in 1 CARTON contains a BLISTER PACK
4 10 TABLET in 1 BLISTER PACK This package is contained within the CARTON (65862-329-10)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090124 08/04/2008
Labeler — Aurobindo Pharma Limited (650082092)
Establishment
Name Address ID/FEI Operations
Aurobindo Pharma Limited 918917642 ANALYSIS (65862-327), ANALYSIS (65862-328), ANALYSIS (65862-329), MANUFACTURE (65862-327), MANUFACTURE (65862-328), MANUFACTURE (65862-329)

Revised: 10/2021 Aurobindo Pharma Limited

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.